brand names of glp-1 drugs Comparing Ozempic, Wegovy and Other How GLP-1 medications are transforming
Description
Despite the promise of these new therapies to address all parts of the CVD/diabetes/obesity triad, approval and broad reimbursement for all these uses are likely still a few years off
(2016b) 145-146:98120
Pozzi M, Mazhar F, Peeters GGAM, Vantaggiato C, Nobile M, Clementi E, et al
Many patients experience modest weight loss while taking it, though it is not officially approved for obesity treatment
It embraced them
